Search

Search Results
Results 191 - 200 of 205 for Mental illness
  • Odaplix SR
    Drug - 26 Jul 2022
    Consumer Medicine Information (CMI) about Odaplix SR (Sustained Release tablets containing indapamide) intended for persons living in Australia.
  • Prexum Combi
    Drug - 20 Jul 2022
    Consumer Medicine Information (CMI) about Prexum Combi (perindopril and indapamide) intended for persons living in Australia.
  • Coversyl Plus
    Drug - 20 Jul 2022
    Consumer Medicine Information (CMI) about Coversyl Plus (perindopril and indapamide) intended for persons living in Australia.
  • DBL Glyceryl Trinitrate
    Drug - 27 Jun 2022
    Consumer Medicine Information (CMI) about DBL Glyceryl Trinitrate intended for persons living in Australia.
  • Metermine
    Drug - 15 Jun 2022
    Consumer Medicine Information (CMI) about Metermine intended for persons living in Australia.
  • Aurorix
    Drug - 21 Mar 2022
    Consumer Medicine Information (CMI) about Aurorix intended for persons living in Australia.
  • Amira 150 and Amira 300
    Drug - 21 Mar 2022
    Consumer Medicine Information (CMI) about Amira 150 and Amira 300 intended for persons living in Australia.
  • Invega Hafyera
    Drug - 23 Feb 2022
    Consumer Medicine Information (CMI) about Invega Hafyera intended for persons living in Australia.
  • Hysone
    Drug - 28 Nov 2021
    Consumer Medicine Information (CMI) about Hysone intended for persons living in Australia.
  • Rikodeine
    Drug - 26 Oct 2021
    Consumer Medicine Information (CMI) about Rikodeine intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback